Nomination Committee at Probi AB

Probi’s Nomination Committee prior to the 2013 Annual General Meeting comprises
the following individuals:
Heinz-Jürgen Bertram, Symrise
Erik Sjöström, Skandia
Bengt Jeppsson, Professor in the surgery unit, Lund University

Erik Sjöström and Bengt Jeppsson were appointed at Probi’s Annual General
Meeting on 26 April 2012. Heinz-Jürgen Bertram, CEO Symrise, replaces Ragnhild
Wiborg, Consepio, pursuant to the policy procedure for changes in the ownership
structure, as established at the Annual General Meeting on 26 April 2012.

The Annual General Meeting of Probi AB will be held in Lund on Wednesday 24
April 2013, at 15.00 (CET).

Shareholders who would like to contact the Nomination Committee may do so by
letter addressed to “Nomination Committee, Probi AB, att: Sofie Forsman, Ideon
Gamma 1, SE-223 70 Lund, Sweden” or by e-mailing sofie.forsman@probi.se

Shareholders who would like an item addressed at the Annual General Meeting must
submit a written proposal to the Chairman of the Board not later than Friday 8
March 2013. Such proposals must be sent by letter addressed to “Annual General
Meeting, Probi AB, att: Sofie Forsman, Ideon Gamma 1, SE-223 70 Lund, Sweden”,
or by e-mail to sofie.forsman@probi.se.

This is the type of information that Probi AB is required to disclose in
accordance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act.

FOR MORE INFORMATION, PLEASE CONTACT:
Per Lundin, Chairman of the Board, Probi, mobile +46 705 74 11 71, e-mail:
per.lundin@transit.se
Michael Oredsson, CEO, Probi, tel +46 46 286 89 23 or mobile +46 707 18 89 30, e
-mail: michael.oredsson@probi.se

ABOUT PROBI
Probi is a leading player in probiotic research and the development of efficient
and well-documented probiotics. Its research areas include: gastrointestinal
tracts, immune system, metabolic syndrome and stress and recovery. Probi’s
customers are leading companies in the functional foods and consumer healthcare
business areas. Total income for 2011 totalled MSEK 95.0. Probi’s share is
listed on the Nasdaq OMX Stockholm, Small Cap. Probi has approximately 5,000
shareholders. For moreinformation, please visit www.probi.se.